ERK1-mediated immunomodulation of mesenchymal stem cells ameliorates inflammatory disorders
Summary: Immune system disorders, especially T cell disorders, are important therapeutic targets of mesenchymal stem cells (MSCs) in many autoimmune diseases (ADs). Although extracellular regulated protein kinases (ERKs) play a role in MSC therapy by promoting T cell apoptosis, the mechanism remains...
| Published in: | iScience |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-10-01
|
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2589004223019454 |
